Literature DB >> 1325478

The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning.

W Fals-Stewart1, J Schafer.   

Abstract

The relationship between neurocognitive functioning and length of stay in drug-free therapeutic communities (TCs) was investigated. The Wechsler Adult Intelligence Scale (WAIS) was administered to 495 patients admitted to a therapeutic community. It was hypothesized that Digit Symbol and Block Design, which have been found to be more sensitive to diffuse neuropsychological impairment than other WAIS subtests, would be significant predictors of length of stay. A hierarchical regression analysis was performed, and both subtests were found to be predictive of time-in-residence. These findings are congruent with recent investigations that have found a relationship between cognitive impairment and treatment process and outcome in substance abuse treatment.

Entities:  

Mesh：

Year:  1992        PMID： 1325478     DOI： 10.1002/1097-4679(199207)48:4<539::aid-jclp2270480416>3.0.co;2-i

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN： 0021-9762


  19 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

2.  The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina.

Authors:  Kimber L Price; Stacia M DeSantis; Annie N Simpson; Bryan K Tolliver; Aimee L McRae-Clark; Michael E Saladin; Nathaniel L Baker; Mark T Wagner; Kathleen T Brady
Journal:  Am J Addict       Date:  2011-07-18

Review 3.  Behavioral therapies trials: a case example.

Authors:  Marianne T Marcus; Patricia R Liehr; Joy Schmitz; F Gerald Moeller; Paul Swank; Micki Fine; Stanley Cron; L Kian Granmayeh; Deidra D Carroll
Journal:  Nurs Res       Date:  2007 May-Jun       Impact factor: 2.381

4.  Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.

Authors:  Marilyn Huckans; Clare J Wilhelm; Tamara J Phillips; Elaine T Huang; Rebekah Hudson; Jennifer M Loftis
Journal:  Neuropsychobiology       Date:  2018-01-18       Impact factor: 2.328

5.  A randomized controlled trial of cognitive remediation and work therapy in the early phase of substance use disorder recovery for older veterans: Neurocognitive and substance use outcomes.

Authors:  Morris D Bell; Holly B Laws; Ismene B Petrakis
Journal:  Psychiatr Rehabil J       Date:  2016-10-10

Review 6.  Cognitive function as an emerging treatment target for marijuana addiction.

Authors:  Mehmet Sofuoglu; Dawn E Sugarman; Kathleen M Carroll
Journal:  Exp Clin Psychopharmacol       Date:  2010-04       Impact factor: 3.157

7.  Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change.

Authors:  Marsha E Bates; Anthony P Pawlak; J Scott Tonigan; Jennifer F Buckman
Journal:  Psychol Addict Behav       Date:  2006-09

8.  Treatment compliance in patients with comorbid psychiatric and substance use disorders.

Authors:  Diane M Herbeck; Diana J Fitek; Dace S Svikis; Ivan D Montoya; Steven C Marcus; Joyce C West
Journal:  Am J Addict       Date:  2005 May-Jun

9.  Cognition, commitment language, and behavioral change among cocaine-dependent patients.

Authors:  Efrat Aharonovich; Paul C Amrhein; Adam Bisaga; Edward V Nunes; Deborah S Hasin
Journal:  Psychol Addict Behav       Date:  2008-12

10.  Social support and cognitive impairment in clients receiving treatment for alcohol- and drug-use disorders: a replication study.

Authors:  Jennifer F Buckman; Marsha E Bates; Jon Morgenstern
Journal:  J Stud Alcohol Drugs       Date:  2008-09       Impact factor: 2.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.